iOS
Android
Facebook
WhatsApp
Twitter
Nebzmart SI contains salbutamol sulphate and ipratropium bromide as active ingredients. It is indicated for the management of bronchospasms in patients suffering from chronic obstructive pulmonary disease who require regular treatment with both ipratropium and salbutamol.
Adults; 1 nebule three or four times a day. Patients should be advised to consult a doctor in the case of acute or rapidly worsening dyspnea.
Nebzmart SI is contraindicated in patients with hypertrophic obstructive cardiomyopathy or tachyarrhythmia. It is also contraindicated in patients with history of hypersensitivity to any components of this medication. Adverse effects may include: headache, throat irritation, cough, dry mouth, nausea and dizziness. The following information is an educational aid only. It is not indicated as medical advice or treatment. Consult your Doctor on safety and effectiveness.
KES 1,435.00
Delivery within 4 hours on all orders placed between 8:00 AM & 8:00 PM
